Abstract:The clinical application of technological progress in the identification of DNA alterations has always led to improvements of diagnostic yields in genetic medicine. At chromosome side, from cytogenetic techniques evaluating number and gross structural defects to genomic microarrays detecting cryptic copy number variants, and at molecular level, from Sanger method studying the nucleotide sequence of single genes to the high-throughput next-generation sequencing (NGS) technologies, resolution and sensitivity progressively increased expanding considerably the range of detectable DNA anomalies and alongside of Mendelian disorders with known genetic causes. However, particular genomic regions (i.e., repetitive and GC-rich sequences) are inefficiently analyzed by standard genetic tests, still relying on laborious, time-consuming and low-sensitive approaches (i.e., southern-blot for repeat expansion or long-PCR for genes with highly homologous pseudogenes), accounting for at least part of the patients with undiagnosed genetic disorders. Third generation sequencing, generating long reads with improved mappability, is more suitable for the detection of structural alterations and defects in hardly accessible genomic regions. Although recently implemented and not yet clinically available, long read sequencing (LRS) technologies have already shown their potential in genetic medicine research that might greatly impact on diagnostic yield and reporting times, through their translation to clinical settings. The main investigated LRS application concerns the identification of structural variants and repeat expansions, probably because techniques for their detection have not evolved as rapidly as those dedicated to single nucleotide variants (SNV) identification: gold standard analyses are karyotyping and microarrays for balanced and unbalanced chromosome rearrangements, respectively, and southern blot and repeat-primed PCR for the amplification and sizing of expanded alleles, impaired by limited resolution and sensitivity that have not been significantly improved by the advent of NGS. Nevertheless, more recently, with the increased accuracy provided by the latest product releases, LRS has been tested also for SNV detection, especially in genes with highly homologous pseudogenes and for haplotype reconstruction to assess the parental origin of alleles with de novo pathogenic variants. We provide a review of relevant recent scientific papers exploring LRS potential in the diagnosis of genetic diseases and its potential future applications in routine genetic testing.

The status quo and future prospects of the next generation sequencing technologies in clinical diagnostics

Next-generation sequencing in the clinic: Promises and challenges

[A consensus on the standardization of the next generation sequencing process for the diagnosis of genetic diseases (3) - Data analysis].

Development of high-throughput sequencing and its application and prospect in clinical molecular diagnosis

Next Generation Sequencing Technology and Its Application in Detecting Gene Mutations

Next-generation sequencing and its applications in molecular diagnostics

Application of Next Generation Sequencing in Laboratory Medicine

Coming of age: ten years of next-generation sequencing technologies

Clinical Next Generation Sequencing for Precision Medicine in Cancer

Next-generation sequencing technologies: breaking the sound barrier of human genetics

Challenges in the application of NGS in the clinical laboratory

The application of long-read sequencing in clinical settings

Next Generation Sequencing: Latent Applications in Clinical Diagnostics with the advent of Bioinformatic Frameworks

Next Generation Sequencing Technology in the Clinic and Its Challenges

Next-generation Molecular Diagnosis: Single-Cell Sequencing from Bench to Bedside

Toward Clinical Implementation of Next-Generation Sequencing-Based Genetic Testing in Rare Diseases: Where Are We?

Next-Generation Sequencing Technology: Current Trends and Advancements

A review of consensus statements, practice resources, standards and guidelines for clinical applications of next-generation sequencing technologies in the United States

The Application of Next Generation Sequencing on Non-Invasive Prenatal Testing: Today and Tomorrow

Emerging technologies for prenatal diagnosis: The application of whole genome and RNA sequencing

Long read sequencing on its way to the routine diagnostics of genetic diseases